Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 27-02 / BIG 1-02 (CALOR) 

A randomized clinical trial of adjuvant chemotherapy for radically resected loco-regional relapse of breast cancer

Chemotherapy as Adjuvant for LOcally Recurrent (CALOR)

Chemotherapy vs. observation

DESIGN

Design 27-02

Study Chairs
Prof. Stefan Aebi - Bern, Switzerland
Dr. Irene Wapnir - Stanford, USA

Statistician
Shari Gelber

Trial Coordinators
Holly Shaw

Data Managers
Karolyn Scott

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097
Email: ibcsg27@fstrf.org

Date of Activation
July 31, 2002

Targeted Accrual
977 patients


Other Pathology


News

01.10.2014:
Benefiz-Gala mit Anton Mosimann Mittwoch 1. Oktober 2014 18.30 Uhr AURA, Bleicherweg 5, 8001 Zürich

11.09.2014:
The next IBCSG Annual Meeting will take place in Vienna, Austria on March 21st and 22nd, 2015 in

11.09.2014:
Breast Cancer Conference BCC 2015 18 - 21 March 2015 / Vienna / Austria  

All News

 
  Print